Author: medweb
-
Remembering Former Chair of Orthopaedic Surgery Michael Schafer, MD
The longest-serving chair in the department’s history, Schafer will be remembered as an excellent surgeon, a trusted mentor and a visionary leader.
-
Disrupting Gene Transcription Elongation to Treat Cancer
Targeting cancer cells with a transcription elongation inhibitor delayed tumor progression in animal models, according to a recent Northwestern Medicine study.
-
Neural Mechanism for Error Correction in Motor Activity Uncovered
Northwestern Medicine scientists have discovered a mechanism for rapid, fine adjustments in motor plans, according to a recent study.
-
Quality of Life Holds Steady With Prostate Cancer Drug
In a recent clinical trial, a drug called apalutamide added to standard therapy slowed cancer progression in men with prostate cancer, while maintaining quality of life.
-
New Discovery Opens Path to Treatments for Hearing Loss
In a study published in Nature, Northwestern Medicine scientists have demonstrated that a gene is critical for the development of the ear’s outer hair cells, which has important implications for hearing loss treatments.
-
Rising Estrogen Levels May Cause Common Men’s Hernias
A Northwestern Medicine study has demonstrated that an age-related increase in estrogen may be the culprit behind a common hernia in elderly men.
-
Addressing the Lack of Women in Orthopaedic Surgery
Linda Suleiman, MD, ’17 GME, assistant professor of Orthopaedic Surgery, discusses her recent study on the representation of women in orthopaedic surgery.
-
Prindle Receives 2018 Packard Fellowship
Arthur Prindle, PhD, assistant professor of Biochemistry and Molecular Genetics, will study bacterial communication and its potential applications to human health with a five-year grant from The David and Lucile Packard Foundation.
-
Alzheimer’s Drug Shows Promise, But Risk Remains
An experimental genetic inhibitor that could stave off Alzheimer’s disease has unintended consequences, but may represent a target for future drug development, according to a recent study.
-
Drug Shows Promise for Progressive Multiple Sclerosis
An oral therapy called ibudilast significantly reduced the rate of brain tissue loss in patients with progressive multiple sclerosis, according to the results of a phase II trial.
